EUS-guided celiac plexus neurolysis by using highly viscous phenol-glycerol as a neurolytic agent (with video) - 01/06/16
Doi : 10.1016/j.gie.2014.10.031
Hirotoshi Ishiwatari, MD, PhD 1, ⁎, Tsuyoshi Hayashi, MD, PhD 1, Makoto Yoshida, MD, PhD 1, Michihiro Ono, MD 1, Tsutomu Sato, MD, PhD 1, Koji Miyanishi, MD, PhD 1, Yasushi Sato, MD, PhD 1, Rishu Takimoto, MD, PhD 1, Masayoshi Kobune, MD, PhD 1, Hiroyuki Masuko, BPharm 2, Atsushi Miyamoto, MP, PhD 2, Tomoko Sonoda, DDS, PhD 3, Junji Kato, MD, PhD 1
1 Department of Medical Oncology and Hematology, Sapporo Medical University, Sapporo, Japan
2 Department of Hospital Pharmacy, Sapporo Medical University, Sapporo, Japan
3 Department of Public Health, Sapporo Medical University, Sapporo, Japan
∗Reprint requests: Hirotoshi Ishiwatari, MD, PhD, Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, 060-8543 Sapporo, Japan.
Abbreviations : CA, CP, CPN, EUS-CPN
Plan
| DISCLOSURE: All authors disclosed no financial relationships relevant to this article. |
© 2015
American Society for Gastrointestinal Endoscopy. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 81 - N° 2
P. 479-483 - février 2015 Retour au numéro
Article précédent
- A novel method for esophageal stent placement: retroflexed endoscopic guidance from the stomach
- Ashish R. Shah, Imad Elkhatib, Mary L. Krinsky
- Esophageal adenocarcinoma in Barrett’s esophagus with low-grade dysplasia
- Benjamin L. Mitlyng, Sam Leon, Robert A. Ganz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?